RYTARY: payments to doctors
Payments that named RYTARY as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.3M
- Providers
- 6,862
- Transactions
- 46,579
- Average per transaction
- $114
The per-transaction average — $114 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,862 providers the average total is $777, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Amneal Pharmaceuticals LLC | $5,330,857 | 100.0% |